In the paper published in Nature Communications, the novel drug CT-179 was shown to target a specific subset of tumor cells responsible for recurrence and therapy resistance in pediatric brain cancer.

After receiving joyful news, Isabella Strahan has hit another setback as she continues to battle medulloblastoma, a tumor that starts in the back part of the brain. On Friday, the 19-year-old daughter ...